Symvan Capital

About The Fund

Symvan Capital is a London-based venture capital firm specializing in investments ranging from seed to Series A stages primarily in the technology sectors. The fund focuses on innovative companies within the Software (Web Marketplace SaaS), IT (& TMT), and HealthTech (& Fitness) industries, leveraging its expertise in equity investments. Symvan Capital offers a comprehensive approach to investing, identifying high-potential startups and guiding them through growth to successful exits. With a minimum and maximum investment size of £150,000, the fund is equipped to support early-stage ventures that have the potential to deliver significant returns. Through a rigorous due diligence process named 'Symvan Select,' the firm meticulously evaluates opportunities and invests in entrepreneurs who have firsthand experience of the challenges they seek to address and have crafted solutions with a potential for disruption. Symvan Capital's investment strategy focuses on backing founders who bring innovative solutions to identifiable problems. Their mantra of embracing disruption and facilitating growth encompasses the desire to assist startups from initial funding rounds to the achievement of Series A milestones or beyond, ensuring solid governance and strategic direction. Investors in Symvan Capital can expect exposure to promising tech startups, with the fund's 'life-cycle' investment approach prioritizing a small selection of well-researched companies for potential exits. The firm's effectiveness is reflected in the efficiency of issuing EIS3 certificates, bolstering their reputation for delivering value. By operating within a niche market and displaying a long-term commitment to the businesses they back, Symvan Capital creates an environment conducive to success, fostering both disruption and fruitful returns.